SEC Comment Letter 0000000000-22-012422 to MediWound Ltd. (MDWD)
MediWound Ltd.
Date: Nov. 16, 2022 · CIK: 0001593984 · Accession: 0000000000-22-012422
AI Filing Summary & Sentiment
File numbers found in text: 333-268297
Letter
United States securities and exchange commission logo November 16, 2022 Ofer Gonen Chief Executive Officer MediWound Ltd. 42 Hayarkon Street Yavne 8122745, Israel Re:MediWound Ltd. Registration Statement on Form F-1 Filed November 10, 2022 File No. 333-268297 Dear Ofer Gonen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Michael J. Rosenberg, Esq.
Show Raw Text
United States securities and exchange commission logo
November 16, 2022
Ofer Gonen
Chief Executive Officer
MediWound Ltd.
42 Hayarkon Street
Yavne 8122745, Israel
Re:MediWound Ltd.
Registration Statement on Form F-1
Filed November 10, 2022
File No. 333-268297
Dear Ofer Gonen:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Michael J. Rosenberg, Esq.